Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
OFS Credit Company Announces Financial Results for the First Fiscal Quarter 2025
-
Franklin Templeton Announces 19(a) Notices for Closed-End Municipal Funds
-
Patient-Centric Data Capture Fuels Growth of Target RWE Longitudinal, Real-World Dermatology Studies
-
Virpax Looking to Use MET to Develop Intranasal COVID Vaccine
-
SeekOps Names Brendan Smith as CEO
-
PINSTACK Expands in Dallas-Fort Worth
-
Temple to Join Forces with Blue Zones to Help Transform the Health of the Community
-
Redfin Report: U.S. Asking Rents Rose 0.4% in February—A Small Increase, But the First in 6 Months
-
IS&S to Participate in the Investor Summit Virtual Conference
-
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
-
“Rule Beyond the Ring” in WWE® 2K25; The Bloodline Edition and Deadman Edition Available Now Worldwide
-
SABINE ROYALTY TRUST ANNOUNCES MONTHLY CASH DISTRIBUTION FOR MARCH 2025
-
Hurco Reports First Quarter Results for Fiscal Year 2025
-
Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025
-
Auna Signs Exclusive Five-Year Agreement with Leading Oncology Group to Strengthen Oncology Services in Monterrey
-
Affinity Bancshares, Inc. Adopts Stock Repurchase Program
-
Ameris Bank Donates Nearly $1.7 Million to 17 Georgia Hospitals
-
UroGen Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Record-Breaking Ethernet Data Center Switch Sales Fueled by Robust AI Buildouts and a Recovery in Traditional Front-End Networks, According to Dell'Oro Group
-
Xevant Introduces the All-New Biosimilar Dashboard, A Real-Time Analytics Tool to Accelerate Biosimilar Adoption and Reduce Unnecessary Biologic Drug Spend
-
KB Home Announces the Grand Opening of Its Newest Community in Northern Johnston County, North Carolina
-
InflaRx Showcases Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
-
Lifeward Ltd. Reports Fourth Quarter and Full Year 2024 Financial Results
-
Nimbus Therapeutics Appoints Abbas Kazimi as Chief Executive Officer
-
Fold Adds 475 Bitcoin to Treasury, Securing Top 10 Position Among U.S. Public Bitcoin Treasuries
-
Dual WEE1/YES1 Kinase Inhibitor MRANK-106 Secures FDA IND Clearance, Positioning MindRank in First-in-Class Oncology Pipeline
-
LIS Technologies Inc. (“LIST”) Awarded AFWERX SBIR Phase I - Updated
-
AskBio Advances Gene Therapy Clinical Trial for Limb-Girdle Muscular Dystrophy Type 2I/R9 with Dosing of First Participant in Second Cohort
-
Verizon to speak at Deutsche Bank Conference March 11
-
GraniteShares 2x Long MARA Daily ETF (MRAL) and GraniteShares 2x Long MRVL Daily ETF (MVLL) Launch Today
-
Prometheus Energetics to Establish an Approximate 550 Acre Solid Rocket Motor and Munitions Production Facility in Indiana as Part of DOD’s Munitions Campus Pilot Program Led by the American Center
-
Arcutis to Highlight Data from Phase 3 Trials for Scalp and Body Psoriasis and Atopic Dermatitis at the 83rd American Academy of Dermatology Meeting
-
Brera Holdings Adds Famed Global Economist Dr. Arthur B. Laffer to Its All-Star Advisory Board
-
ProPhase Labs to Present at the Investor Summit Virtual on March 11
-
PodcastOne (NASDAQ: PODC) to participate in the 37th Annual ROTH Conference on March 16-18, 2025, in California
-
Michelin | Disclosure of the total number of voting rights and of the number of shares making up the Company’s capital
-
Prometheus Energetics to Establish an Approximate 550 Acre Solid Rocket Motor and Munitions Production Facility in Indiana as Part of DOD’s Munitions Campus Pilot Program Led by the American Center
-
Sibannac Launches Starwalker Cafe – A Transformational Hub for Consciousness Exploration, Wellness Journeys, and Lifestyle Growth
-
Christine Blosdale's Latest Book Becomes a #1 Amazon Bestseller: "The Social Media and Branding Survival Guide"
-
Koppers Announces Participation in Upcoming Investor Conferences
-
abrdn Asia-Pacific Income Fund VCC Meeting Adjourned To Friday, March 14, 2025
-
Dr. Zachary Solomon Launches $1,000 Scholarship to Support Future Medical Leaders
-
Invesco Ltd: Form 8.3 - Aviva PLC; Public dealing disclosure
-
Frisch’s Big Boy’s National Tartar Sauce Day is Friday, March 7
-
NuRAN Anticipates No Impact on Impending Tariff Changes
-
Plus Therapeutics Announces Peer-Reviewed Publication in Nature Communications Highlighting Promising Phase 1 Results for Rhenium (186Re) Obisbemeda in Glioblastoma
-
Aucera Wins Five Stevie® Awards for Excellence in Customer Experience, Innovation, and BPO Leadership
-
Zimmer Biomet Receives FDA Clearance for Persona® Revision SoluTion™ Femur
-
DeFi Technologies Acquires Majority Stake in Swiss Artificial Intelligence and Asset Management Firm Neuronomics AG
-
Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
